Miralax /00754501/


Indications and Reactions:

Role Indications Reactions
Concomitant
Product Used For Unknown Indication 70.5%
Pain 6.4%
Constipation 4.0%
Prophylaxis 3.0%
Nausea 2.3%
Anxiety 1.2%
Vomiting 1.2%
Back Pain 1.1%
Insomnia 1.0%
Depression 1.0%
Hypertension 1.0%
Asthma 0.9%
Cardiac Failure Congestive 0.9%
Hepatitis C 0.9%
Non-small Cell Lung Cancer 0.9%
Antioxidant Therapy 0.8%
Osteoporosis 0.8%
Arthritis 0.8%
Gastrooesophageal Reflux Disease 0.7%
Migraine 0.7%
Death 13.8%
Vomiting 11.3%
Drug Ineffective 7.5%
Granulocytopenia 6.3%
Weight Decreased 6.3%
Fatigue 5.0%
Hospitalisation 5.0%
Nausea 5.0%
Therapeutic Response Decreased 5.0%
Urinary Tract Infection 5.0%
Incorrect Dose Administered 3.8%
Leukopenia 3.8%
Toxicity To Various Agents 3.8%
Wrong Technique In Drug Usage Process 3.8%
Cellulitis 2.5%
Chest Pain 2.5%
Diarrhoea 2.5%
Eye Swelling 2.5%
Hypoglycaemia 2.5%
Inappropriate Schedule Of Drug Administration 2.5%

Drug Data